Treat to target in systemic lupus erythematosus: a commentary

dc.contributor.authorUgarte-Gil, M.F.es_ES
dc.contributor.authorBurgos, P.I.es_ES
dc.contributor.authorAlarcón, G.S.es_ES
dc.date.accessioned6/22/2022 13:33
dc.date.accessioned2022-09-30T16:31:45Z
dc.date.available6/22/2022 13:33
dc.date.available2022-09-30T16:31:45Z
dc.date.issued2016
dc.description.abstractTreat to target (T2T) strategies have proved to be useful in several chronic disorders, including Rheumatoid Arthritis. In systemic lupus erythematosus (SLE), T2T strategy has been proposed in order to control disease activity, improve health-related quality of life, and reduce morbidity and mortality. Remission would be the main target, but a low disease activity state (LDAS) could be an acceptable alternative. However, due to SLE protean manifestations, the operational definitions of both remission and LDAS are still in progress. The definitions of these targets, remission and LDAS, should include a validated disease activity index, the treatments allowed, and the minimum length of time the target should be maintained. Furthermore, achieving these targets should result in better disease outcomes such as reducing damage accrual. This review addresses the current state regarding these possible targets in SLE and the impact of achieving them in intermediate and long-term outcomes of this disease. © 2016, International League of Associations for Rheumatology (ILAR).es_ES
dc.formatapplication/pdfes_ES
dc.identifier.doi10.1007/s10067-016-3346-2es_ES
dc.identifier.urihttps://doi.org/10.1007/s10067-016-3346-2
dc.language.isoenges_ES
dc.publisherSpringer-Verlag London Ltdes_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/es_ES
dc.sourceClinical Rheumatologyes_ES
dc.subjectMedicinees_ES
dc.subject.ocdehttp://purl.org/pe-repo/ocde/ford#3.00.00es_ES
dc.titleTreat to target in systemic lupus erythematosus: a commentaryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_ES
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
183. Treat to target in systemic lupus erythematosus a commentary.pdf
Tamaño:
259.05 KB
Formato:
Adobe Portable Document Format
Colecciones